Skip to main content

Table 1 Parameters used to estimate the health burden due to NCCa-associated epilepsy and headache (migraine and tension-type) in Angónia district

From: Assessment of the societal cost of Taenia solium in Angónia district, Mozambique

Parameter Mean (95% UIb) Distributions Reference
Mortality due to epilepsy
per 1000
0.08 (0.076–0.084) Uniform
(7.6e-05, 8.4e-05)
[28]
Prevalence of active epilepsy (%) 1.3 (0.8–1.9) Beta
(22, 1701)
[15]
Proportions
 Epilepsy associated to NCC (%) 51 (43–59) Uniform
(0.427, 0.592)
[15]
 Epilepsy patients receiving treatment (%) 15 (9.4–21) Beta
(22, 129)
[15]
 Headache among people with lifetime epilepsy (%) 62 (54–70) Beta
(94, 57)
[23]
 Migraine among people with headache and epilepsy (%) 39 (30–50) Beta
(37, 57)
[23]
 Tension-type headache among people with headache and epilepsy (%) 61 (50–70) Beta
(57, 37)
[23]
Disability weights
 Epilepsy    GBDc 2010 [31]
 Untreated 0.426 (0.286–0.565) Uniform
(0.279, 0.572)
 
 Treated, seizure free 0.076 (0.048–0.105) Uniform
(0.047, 0.106)
 
 Headache    GBDc 2013 [32]
 Migraine 0.441 (0.301–0.581) Uniform
(0.294, 0.588)
 
 Tension-type 0.040 (0.023–0.056) Uniform
(0.022, 0.057)
 
  1. a NCC neurocysticercosis; b UI uncertainty interval; c GBD 2010, 2013: Global Burden of Disease Study 2010 and 2013